Holen Sie sich die Stockscreener-App
10.54
1.95%
-0.21
Handel nachbörslich:
10.33
-0.21
-1.99%
Schlusskurs vom Vortag:
$10.75
Offen:
$10.755
24-Stunden-Volumen:
612.08K
Relative Volume:
0.72
Marktkapitalisierung:
$567.37M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-10.54
EPS:
-1
Netto-Cashflow:
$-100.85M
1W Leistung:
+1.64%
1M Leistung:
+6.25%
6M Leistung:
+24.00%
1J Leistung:
-36.70%
1-Tages-Spanne:
$10.40
$11.17
1-Wochen-Bereich:
$10.34
$11.69
52-Wochen-Spanne:
$4.32
$18.77
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Vergleichen Sie PRTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
10.54 | 578.67M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
What’s the recovery path for long term holders of Prothena Corporation plcTrade Volume Summary & Verified Swing Trading Watchlist - newser.com
Will Prothena Corporation plc stock maintain momentum in 2025Weekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Will Prothena Corporation plc stock see insider buyingQuarterly Profit Review & Accurate Buy Signal Alerts - newser.com
Is this a good reentry point in Prothena Corporation plcAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Should you hold or exit Prothena Corporation plc nowPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
Should you wait for a breakout in Prothena Corporation plcPortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Signal strength of Prothena Corporation plc stock in tech scannersInflation Watch & Fast Entry Momentum Alerts - newser.com
Will Prothena Corporation plc stock recover faster than marketQuarterly Portfolio Report & Low Volatility Stock Recommendations - newser.com
Market reaction to Prothena Corporation plc’s recent newsJuly 2025 Review & Entry Point Confirmation Alerts - newser.com
How Prothena Corporation plc stock trades before earningsDollar Strength & High Yield Equity Trading Tips - newser.com
What MACD and RSI say about Prothena Corporation plc2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Using portfolio simulators with Prothena Corporation plc includedTrade Exit Report & Safe Capital Growth Plans - newser.com
Will Prothena Corporation plc stock reach all time highs in 2025Weekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Risk vs reward if holding onto Prothena Corporation plcWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Prothena (PRTA) to Release Quarterly Earnings on Thursday - MarketBeat
What analysts say about Prothena Corporation plc stockFlag and Pennant Patterns & Accelerated Capital Growth - earlytimes.in
Will Prothena Corporation plc stock see PE expansionJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Applying chart zones and confluence areas to Prothena Corporation plcJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
What to expect from Prothena Corporation plc in the next 30 daysWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):